Latest News & Events
Hemanext Inc. Announces a Significant Milestone with FDA Marketing Authorization for Hemanext ONE®, Hemanext’s Innovative Red Blood Cell (RBC) Processing and Storage System
Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo...
Hemanext Announces Founder Martin Cannon’s Retirement, Appoints Andrew Dunham as CEO, and Raises Funding for Growth
LEXINGTON, Mass., September 18, 2023, – Hemanext Inc., a leading innovator in blood processing,...
Hemanext Announces Membership in European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)
LEXINGTON, Mass., July 5, 2023, – Hemanext Inc., a leading innovator in blood processing, storage,...
Hemanext Announces a Strategic Partnership and Investment from Vitalant
Partnership to include research and development at Vitalant Innovation Center LEXINGTON, Mass.,...
Hemanext Research
Learn more about Hemanext and take a closer look at our publications, studies, and posters focused on blood quality and red blood cell characterization.